Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma

References

• Castellino SM, Geiger AM, Mertens AC, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2011;117(6):1806–1816.
   PubMed Web of Science ®Google Scholar
• Dietz AC, Chen Y, Yasui Y, et al. Risk and impact of pulmonary complications in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2016;122(23):3687–3696.
   PubMed Web of Science ®Google Scholar
• Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group Long-Term Follow-Up Guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline. JCO. 2004;22(24):4979–4990.
   PubMed Web of Science ®Google Scholar
• Liles A, ., Blatt J, Morris D, et al. Monitoring pulmonary complications in long-term childhood cancer survivors: guidelines for the primary care physician. Cleve Clin J Med. 2008;75(7):531–539.
   PubMed Web of Science ®Google Scholar
• Aremenian SH, et al. Long-term pulmonary function in survivors of childhood cancer. J Clin Oncol. 2015;33(14):1592–1600.
   PubMed Web of Science ®Google Scholar
• Green DM, Zhu L, Wang M, et al. Pulmonary function after treatment for childhood cancer. A report from the St. Jude Lifetime Cohort Study (SJLIFE). Annals Ats. 2016;13(9):1575–1585.
   Web of Science ®Google Scholar
• Mulder RL, Thonissen NM, van der Pal HJ, et al. Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer. Thorax. 2011;66(12):1065–1071.
   PubMed Web of Science ®Google Scholar
• De A, Guryev I, LaRiviere A, et al. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin. Pediatr Blood Cancer. 2014;61(9):1679–1684. Sep
   PubMed Web of Science ®Google Scholar
• Record E, Williamson R, Wasilewski-Masker K, et al. Analysis of risk factors for abnormal pulmonary function in pediatric cancer survivors. Pediatr Blood Cancer. 2016;63(7):1264–1271. Jul
   PubMed Web of Science ®Google Scholar
• Venkatramani R, Kamath S, Wong K, et al. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys. 2013;86(5):942–948.
   PubMed Web of Science ®Google Scholar
• Zorzi AP, Yang CL, Dell S, et al. Bleomycin-associated lung toxicity in childhood cancer survivors. J Pediatr Hematol Oncol. 2015;37(8):e447–52. Nov
   PubMed Web of Science ®Google Scholar
• Graham BL, Brusasco V, Burgos F, et al. Executive summary: 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968.
   PubMed Web of Science ®Google Scholar
• Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13(3):176–181.
   PubMed Web of Science ®Google Scholar
• Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. Am J Roentgenol. 1997;169(4):977–983.
   PubMed Web of Science ®Google Scholar
• Kelly KM, Hodgson D, Appel B, et al. Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma. Pediatr Blood Cancer. 2013;60(6):972–978.
   PubMed Web of Science ®Google Scholar
• von der Weid NX. Adult life after surviving lymphoma in childhood. Support Care Cancer. 2008;16(4):339–345.
   PubMed Web of Science ®Google Scholar
• Venkatramani R, Kamath S, Wong K, et al. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatr Blood Cancer. 2014;61(7):1277–1281.
   PubMed Web of Science ®Google Scholar
• Nysom K, Holm K, Hertz H, et al. Risk factors for reduced pulmonary function after malignant lymphoma in childhood. Med Pediatr Oncol. 1998;30(4):240–248.
   PubMedGoogle Scholar
• Oguz A, Tayfun T, Citak EC, et al. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma. Pediatr Blood Cancer. 2007;49(5):699–703.
   PubMed Web of Science ®Google Scholar
• Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720–735.
   PubMed Web of Science ®Google Scholar
• Lewis GD, Agrusa JE, Teh BS, et al. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest. Pract Radiat Oncol. 2018;8(5):e364–e368.
   PubMed Web of Science ®Google Scholar
• Kelly KM, Cole PD, Chen L, et al. Phase III study of response adapted therapy for the treatment of children with newly diagnosed very high risk hodgkin lymphoma (stages IIIB/IVB) (AHOD0831): a report from the Children’s Oncology Group. Blood. 2015; 126(23):3927–3927.
   Google Scholar
• Friedman DL, Chen L, Wolden S, et al. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children’s Oncology Group Study AHOD0031. JCO. 2014;32(32):3651–3658.
   PubMed Web of Science ®Google Scholar
• Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys. 2006;65(4):1075–1086. 15
   PubMed Web of Science ®Google Scholar
• Rodrigues G, Lock M, D'Souza D, et al. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer-a systematic review. Radiother Oncol. 2004;71(2):127–138.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Sklar CA, Hudson MM, et al. Long-term health status among survivors of childhood cancer: does sex matter? J Clin Oncol. 2007;25(28):4477–4489.
   PubMed Web of Science ®Google Scholar
• Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995;332(26):1738–1743.
   PubMed Web of Science ®Google Scholar